| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 21, 2012 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 49,428 | -- | -- |
| Feb 21, 2012 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | 30,000 |
| Feb 21, 2012 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- |
| Feb 21, 2012 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,438 | -- | -- |
| Dec 16, 2011 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,921 | -- | 1,921 |
| Dec 16, 2011 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 45,000 |
| Dec 16, 2011 |
SVP Clinical Development & Reg
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,079 | -- | 30,079 |
| Aug 02, 2011 |
SVP Clinical Development
|
SVP Clinical Development | Form 4 | Other acquisition or disposition | -- | -- | 1,388 |
| Aug 01, 2011 |
SVP Clinical Development
|
SVP Clinical Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,144 | $15.64 | 15,144 |
| Aug 01, 2011 |
SVP Clinical Development
|
SVP Clinical Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,144 | -- | 10,428 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.